SLB
45
4
HIG
51
4
MA
64
2
NRG
39
4
QCOM
59
3
ALLE
25
4
EIX
62
3
ROP
48
3
ETN
65
2
FRT
39
3
AVGO
79
3
MPC
31
3
FIS
48
5
NWSA
75
8
NOV
50
3
EQT
48
6
WMB
62
2
IBM
54
3
AON
30
2
BLK
54
4
SLB
45
4
HIG
51
4
MA
64
2
NRG
39
4
QCOM
59
3
ALLE
25
4
EIX
62
3
ROP
48
3
ETN
65
2
FRT
39
3
AVGO
79
3
MPC
31
3
FIS
48
5
NWSA
75
8
NOV
50
3
EQT
48
6
WMB
62
2
IBM
54
3
AON
30
2
BLK
54
4
Financhill
Back

PeptiDream 10K Form

Sell
50

PPTDF
PeptiDream

Last Price:
$17.85
Seasonality Move:
-3.56%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PPTDF News And Ratings

See the #1 stock for the next 7 days that we like better than PPTDF

PPTDF Financial Statistics

Sales & Book Value

Annual Sales: $204.6M
Cash Flow: $173.8M
Price / Cash Flow: 12.97
Annual Sales: $3.16
Price / Book: 5.43

Profitability

EPS (TTM): 0.84160
Net Income (TTM): $109.2M
Gross Margin: $122.7M
Return on Equity: 34.66%
Return on Assets: 20.65%

PeptiDream Earnings Forecast

Key PeptiDream Financial Ratios

  • The Gross Profit Margin over the past 12 years for PPTDF is 59.97%.
  • The Selling, General & Administrative Expenses for PPTDF have been equal to 25.27% of Gross Profit Margin.
  • The Research & Development expenses have been 10.99% of Revenue.
  • The Interest Expense is 74.21% of Operating Income.
  • The Net Earning history of PPTDF is 10.57% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 7 years.

PeptiDream Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: PPTDF
Website: peptidream.com

Debt

Debt-to-Equity Ratio: 0.35
Current Ratio: 3.51
Quick Ratio: 3.28

Price-to-Earnings

Trailing P/E Ratio: 102.92
Forward P/E Ratio: 0

PPTDF Technical Analysis vs Fundamental Analysis

Sell
50
PeptiDream (PPTDF) is a Sell

Is PeptiDream a Buy or a Sell?

  • PeptiDream stock is rated a Sell
    The current PeptiDream [PPTDF] share price is $17.15. The Score for PPTDF is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.